DIFFERENT EFFECTS OF ATORVASTATIN AND ROSUVASTATIN ON CIRCULATING MICRORNAS-126 AND 146A LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Serik, S. [1 ]
Riabukha, V. [1 ]
Mavrycheva, N. [1 ]
Malko, V. [1 ]
Bondar, T. [2 ]
机构：
[1] Natl Acad Med Sci Ukraine, Dept Ischem Heart Dis Metab & Cardiopulmonary Dis, LT Malaya Therapy Natl Inst, Kharkiv, Ukraine
[2] Natl Acad Med Sci Ukraine, LT Malaya Therapy Natl Inst, Lab Immuno Biochem & Mol Genet Res, Kharkiv, Ukraine
来源：
ATHEROSCLEROSIS | 2023年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P429
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [1] Circulating MicroRNA-27.,-126,-146a,-221 levels in Coronary Artery Disease and Type 2 Diabetes Mellitus
    Serhii, Serik
    Emirita, Serdobinska-Kanivets
    Olena, Kurinna
    Tetiana, Bondar
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 31 - 31
  • [2] Dose-dependent effects of rosuvastatin on circulating microRNAs-27a and 221 levels in patients with coronary artery disease with type 2 diabetes mellitus
    Serik, S.
    Riabukha, V.
    Serdobinska-Kanivets, E.
    Bondar, T.
    Ovrakh, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2942 - 2942
  • [3] Effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia
    Mori H.
    Okada Y.
    Tanaka Y.
    Diabetology International, 2013, 4 (2) : 117 - 125
  • [4] Effects of Atorvastatin and Rosuvastatin on Renal Function in Patients With Type 2 Diabetes Mellitus
    Lai, Chao-Lun
    Chou, Hsu-Wen
    Chan, K. Arnold
    Lai, Mei-Shu
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 619 - 624
  • [5] Associations between Circulating MicroRNAs and Coronary Artery Disease in Patients with Type 2 Diabetes
    Geiger, Kathrin
    Muendlein, Axel
    Leiherer, Andreas
    Saely, Christoph H.
    Ebner, Janine
    Brandtner, Eva M.
    Zanolin, Daniela
    Vonbank, Alexander
    Fraunberger, Peter
    Drexel, Heinz
    DIABETES, 2017, 66 : A665 - A665
  • [6] Associations between circulating microRNAs and coronary artery disease in patients with type 2 diabetes
    Muendlein, A.
    Geiger, K.
    Leiherer, A.
    Saely, C. H.
    Ebner, J.
    Brandtner, E. -M.
    Zanolin, D.
    Vonbank, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Fraunberger, P.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S22 - S22
  • [7] CIRCULATING MICRO-146a AND PRO-INFLAMMATORY CYTOKINES IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS
    Serik, S.
    Riabukha, V.
    Malko, V.
    ATHEROSCLEROSIS, 2022, 355 : E262 - E262
  • [8] THE ASSOCIATION OF CIRCULATING MICRORNA-126 WITH INFLAMMATION AND INSULIN RESISTANCE IN PATIENTS WITH CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES MELLITUS
    Serik, S.
    Mavrycheva, N.
    Riabukha, V.
    Malko, V.
    Bondar, T.
    Chenchik, T.
    ATHEROSCLEROSIS, 2023, 379 : S139 - S139
  • [9] Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients
    Al-Kafaji, Ghada
    Al-Mahroos, Ghazi
    Al-Muhtaresh, Haifa Abdulla
    Sabry, Mohamed Abdalla
    Razzak, Rima Abdul
    Salem, Abdel Halim
    BIOMARKERS, 2017, 22 (3-4) : 268 - 278
  • [10] Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients
    Mahjoob, Golnoosh
    Ahmadi, Yasin
    Rajani, Huda Fatima
    Khanbabaei, Nafiseh
    Abolhasani, Sakhavat
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (05)
12345